Acurx Pharmaceuticals, Inc.
USD1.55
-0.13 (-7.74%)
CEO
David Luci
IPO Date
2021-06-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.64
Prev. Close
$1.68
Day Low
$1.52
Day High
$1.67
52W Low
$1.33
52W High
$11.72
Market Cap
$0.00B
Volume
0.10M
| -1.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -312.4% | -189.1% | 0.00 | 2.53 | -3.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -165.3% | -129.0% | 0.00 | 4.55 | -3.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -102.7% | -96.2% | 0.00 | 15.71 | -3.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -170.3% | -142.7% | 0.02 | 6.82 | -17.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -723.5% | -234.3% | 0.00 | 1.48 | -10.0 |
| -0.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -54.8% | -32.6% | 0.00 | 2.47 | -0.9 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -63.0% | -36.5% | 0.00 | 2.38 | -1.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -93.0% | -44.7% | 0.00 | 1.93 | -0.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -452.2% | -72.1% | 0.00 | 1.19 | -1.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -105.9% | -47.2% | 0.00 | 1.80 | -2.8 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -120.3% | -62.6% | 0.00 | 2.09 | -2.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -73.0% | -48.1% | 0.00 | 2.93 | -2.0 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -109.6% | -66.3% | 0.00 | 2.53 | -2.5 |